Filana TherapeuticsFLNA
那斯達克 · USD
0.86
-0.02
(-2.58%)
盤中 07/30 12:40 (UTC+8)
07/30 12:40 (UTC+8)
Filana TherapeuticsFLNA
0.86
-0.02
(-2.58%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | |
營業收入淨額 | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - |
營業費用 | 11,168 | 13,552 | 11,860 | 45,392 | 24,586 | 29,487 | - | - |
研發費用 | 4,544 | 3,853 | 3,955 | 5,116 | 13,666 | 20,530 | - | - |
推銷及管理費用 | 6,624 | 9,699 | 7,905 | 40,276 | 10,920 | 8,957 | - | - |
非經常性項目費用 | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - |
營業利益 | -11,168 | -13,552 | -11,860 | -45,392 | -24,586 | -29,487 | - | - |
其他收入及費用 | 837 | 1,013 | 1,053 | 1,168 | 1,183 | 1,890 | - | - |
利息費用 | - | - | - | - | - | - | - | - |
稅前純益 | -10,331 | -12,539 | -10,807 | -44,224 | -23,403 | -27,597 | - | - |
所得稅 | - | - | - | - | - | - | - | - |
稅後純益 | -10,331 | -12,539 | -10,807 | -44,224 | -23,403 | -27,597 | - | - |
基本每股稅後盈餘(元) | -0.21 | -0.26 | -0.22 | -0.92 | -0.48 | -0.57 | - | - |
稀釋每股稅後盈餘(元) | -0.21 | -0.26 | -0.22 | -0.92 | -0.48 | -0.58 | -0.60 | 0.15 |
基本平均股數(千股) | 48308.00 | 48308.00 | 48308.00 | 48308.00 | 48262.00 | 48099.00 | - | - |
稀釋平均股數(千股) | 48308.00 | 48308.00 | 48308.00 | 48308.00 | 48262.00 | 48099.00 | - | - |
還原基本每股稅後盈餘(元) | -0.21 | -0.26 | -0.22 | -0.92 | -0.48 | -0.57 | - | - |
還原稀釋每股稅後盈餘(元) | -0.21 | -0.26 | -0.22 | -0.92 | -0.48 | -0.58 | -0.60 | 0.15 |
還原基本平均股數(千股) | 48,308 | 48,308 | 48,308 | 48,308 | 48,262 | 48,099 | - | - |
還原稀釋平均股數(千股) | 48,308 | 48,308 | 48,308 | 48,308 | 48,262 | 48,099 | - | - |
EBITDA(千元) | -10,088 | -12,172 | -10,676 | -44,006 | -23,183 | -27,337 | - | - |